Back in 2021, at the height of the pandemic, scientists at Pfizer revealed the development of a novel antiviral molecule, ...

Paratek will accelerate access for XHANCE beyond specialists to primary care providers maximizing the recent label expansion for CRS in a ...

An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on ...

Researchers have found in a new study that among COVID-19 patients with asthma, those who received Paxlovid had a ...

A new study suggests Paxlovid may not reduce the risk of covid-19 hospitalizations and all-cause deaths in vaccinated adults ...

The first to launch was the ACTT-1 trial, though it didn't have that name when it began at the University of Nebraska Medical ...

It’s the third contraceptive pill the federal government has added to the PBS this year, after Yaz and Yasmine. But these two ...

The lack of available medications in the United States for COVID post-exposure prophylaxis leaves household members in close ...

Medicare beneficiaries can get Paxlovid for free through the U.S. Government Patient Assistance Program (USG PAP) until December 31, 2025. Read more.

What's more, Paxlovid may still be helpful for certain high-risk groups, Mafi said. Paxlovid, a combination of nirmatrelvir ...

In the large clinical trials that proved the benefits of statins, about a quarter of people complained of myalgia, although ...